Page last updated: 2024-08-22

rhenium and Ovarian Neoplasms

rhenium has been researched along with Ovarian Neoplasms in 21 studies

*Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. [MeSH]

Research

Studies (21)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	10 (47.62)	18.2507
2000's	2 (9.52)	29.6817
2010's	6 (28.57)	24.3611
2020's	3 (14.29)	2.80

Authors

Authors	Studies
Harris, HH; Huang, Z; King, AP; Lai, B; Lovett, J; Wilson, JJ; Woods, JJ	1
Bileck, A; Borutzki, Y; Gerner, C; Huang, Z; Janker, L; King, AP; Marker, SC; Meier-Menches, SM; Neuditschko, B; Wilson, JJ	1
Boros, E; King, AP; Marker, SC; Qian, SB; Swanda, RV; Vaughn, B; Wilson, JJ	1
Chang, CH; Chang, CM; Chuang, CM; Huang, WS; Lan, KL; Lee, TW; Lee, YJ	1
Chen, D; Tang, Q	1
Altai, M; Honarvar, H; Larsson, E; Löfblom, J; Lubberink, M; Orlova, A; Sandström, M; Ståhl, S; Strand, J; Strand, SE; Tolmachev, V; Varasteh, Z; Wållberg, H	1
Chang, CH; Chen, PH; Chuang, CM; He, CL; Lan, KL; Lee, TW; Lee, YJ; Lin, LT; Shen, YA	1
Cesnavicious, J; Doyle, RP; Rabideau, AE; Viola-Villegas, N; Zubieta, J	1
Ekblad, T; Karlström, AE; Orlova, A; Tolmachev, V; Tran, TA	1
Chen, DZ; Gong, YC; Guo, CQ; Tang, QS; Xiang, JY; Xue, WQ; Zhang, L	1
Fallone, BG; McQuarrie, SA; Middleton, JW; Syme, AM	1
Breitz, HB; Durham, JS; Fisher, DR; Weiden, PL	1
Breitz, HB; DeNardo, GL; Durham, JS; Fisher, DR; Goodgold, HM; Nelp, WB; Weiden, PL	1
Diril, H; Goldenberg, DM; Griffiths, GL; Hansen, HJ; Mattes, MJ; Ong, GL; Shih, LB; Thorpe, SR	1
Breitz, H; Cain, J; Fer, M; Goodgold, H; Heaps, J; Jacobs, AJ; Su, FM; Thompson, J; Weiden, P	1
Boven, E; Kievit, E; Pinedo, HM; Schlüper, HM; van Dongen, GA; van Gog, FB	2
Bier, S; Kwok, CS; Noujaim, AA; Snieckus, V; Somayaji, VV; Sykes, TR; Woo, TK	1
Bundesen, PG; Schmidt, PF; Smith, SV	1
Kerkvliet, GJ	1

Trials

3 trial(s) available for rhenium and Ovarian Neoplasms

Article	Year
Radiation-absorbed dose estimates to normal organs following intraperitoneal 186Re-labeled monoclonal antibody: methods and results. Cancer research, 1995, Dec-01, Volume: 55, Issue:23 Suppl Topics: Antibodies, Monoclonal; Female; Humans; Ovarian Neoplasms; Radioimmunotherapy; Radioisotopes; Radionuclide Imaging; Radiotherapy Dosage; Rhenium	1995
Pharmacokinetics and normal organ dosimetry following intraperitoneal rhenium-186-labeled monoclonal antibody. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1995, Volume: 36, Issue:5 Topics: Female; Humans; Infusions, Parenteral; Ovarian Neoplasms; Radioimmunotherapy; Radioisotopes; Radiotherapy Dosage; Rhenium; Tissue Distribution; Whole-Body Counting	1995
A phase I trial of a rhenium 186-labeled monoclonal antibody administered intraperitoneally in ovarian carcinoma: toxicity and clinical response. Obstetrics and gynecology, 1993, Volume: 82, Issue:4 Pt 1 Topics: Adult; Aged; Carcinoma; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Injections, Intraperitoneal; Middle Aged; Ovarian Neoplasms; Radioimmunotherapy; Radioisotopes; Rhenium; Tissue Distribution; Treatment Outcome	1993

Other Studies

18 other study(ies) available for rhenium and Ovarian Neoplasms

Article	Year
Photochemistry and Chemical communications (Cambridge, England), 2021, Oct-26, Volume: 57, Issue:85 Topics: Antineoplastic Agents; Apoptosis; Cell Membrane Permeability; Computational Biology; Coordination Complexes; Drug Screening Assays, Antitumor; Female; HeLa Cells; Humans; Light; Optical Imaging; Ovarian Neoplasms; Photochemotherapy; Platinum; Rhenium; Spectrometry, X-Ray Emission	2021
An Anticancer Rhenium Tricarbonyl Targets Fe-S Cluster Biogenesis in Ovarian Cancer Cells. Angewandte Chemie (International ed. in English), 2022, 10-24, Volume: 61, Issue:43 Topics: Female; Ferritins; Humans; Iron-Sulfur Proteins; Mitochondria; Ovarian Neoplasms; Rhenium	2022
Exploring Ovarian Cancer Cell Resistance to Rhenium Anticancer Complexes. Angewandte Chemie (International ed. in English), 2020, 08-03, Volume: 59, Issue:32 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Coordination Complexes; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Humans; Metallothionein; NF-E2-Related Factor 2; Ovarian Neoplasms; Rhenium; Verapamil	2020
International journal of molecular sciences, 2017, Apr-25, Volume: 18, Issue:5 Topics: Animals; Autophagy; CA-125 Antigen; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Drug Resistance, Neoplasm; Female; Humans; Liposomes; Mice; Mice, Inbred BALB C; Mice, Nude; Microtubule-Associated Proteins; Mitochondria; Nanomedicine; Neoplastic Stem Cells; Ovarian Neoplasms; Radioisotopes; Radiopharmaceuticals; Rhenium; Transplantation, Heterologous	2017
Study of the therapeutic effect of 188Re labeled folate targeting albumin nanoparticle coupled with cis-diamminedichloroplatinum cisplatin on human ovarian cancer. Bio-medical materials and engineering, 2014, Volume: 24, Issue:1 Topics: Albumins; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cisplatin; Combined Modality Therapy; Drug Carriers; Female; Folic Acid; Humans; Hyperthermia, Induced; Ligands; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasm Transplantation; Ovarian Neoplasms; Radioisotopes; Rhenium	2014
188Re-ZHER2:V2, a promising affibody-based targeting agent against HER2-expressing tumors: preclinical assessment. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:11 Topics: Animals; Antibodies; Cell Line, Tumor; Chelating Agents; Drug Evaluation, Preclinical; Female; Gluconates; Humans; Mice; Mice, Nude; Oligopeptides; Ovarian Neoplasms; Peptides; Radiation Dosage; Radioisotopes; Radiometry; Radiopharmaceuticals; Receptor, ErbB-2; Rhenium; Xenograft Model Antitumor Assays	2014
Intraperitoneal (188)Re-Liposome delivery switches ovarian cancer metabolism from glycolysis to oxidative phosphorylation and effectively controls ovarian tumour growth in mice. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2016, Volume: 119, Issue:2 Topics: Animals; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Female; Glycolysis; Humans; Liposomes; Mice; Ovarian Neoplasms; Oxidative Phosphorylation; Radiation Tolerance; Radioisotopes; Rhenium; Tumor Suppressor Protein p53	2016
Targeting the folate receptor (FR): imaging and cytotoxicity of ReI conjugates in FR-overexpressing cancer cells. ChemMedChem, 2008, Volume: 3, Issue:9 Topics: Animals; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; CHO Cells; Cricetinae; Cricetulus; DNA; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Electrophoretic Mobility Shift Assay; Female; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Inhibitory Concentration 50; Intercalating Agents; Microscopy, Confocal; Molecular Structure; Organometallic Compounds; Ovarian Neoplasms; Receptors, Cell Surface; Reverse Transcriptase Polymerase Chain Reaction; Rhenium; Structure-Activity Relationship; Topoisomerase I Inhibitors	2008
(186)Re-maSGS-Z (HER2:342), a potential Affibody conjugate for systemic therapy of HER2-expressing tumours. European journal of nuclear medicine and molecular imaging, 2010, Volume: 37, Issue:2 Topics: Animals; Antibodies, Monoclonal; Female; Humans; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Organ Specificity; Ovarian Neoplasms; Radiation Dosage; Radioisotopes; Radiometry; Radiopharmaceuticals; Receptor, ErbB-2; Rhenium; Tissue Distribution	2010
Preparation and biodistribution of 188Re-labeled folate conjugated human serum albumin magnetic cisplatin nanoparticles (188Re-folate-CDDP/HSA MNPs) in vivo. International journal of nanomedicine, 2011, Volume: 6 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Drug Stability; Female; Folic Acid; Humans; Hydrogen-Ion Concentration; Hyperthermia, Induced; Magnetite Nanoparticles; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Radioisotopes; Rhenium; Serum Albumin; Temperature; Tin Compounds; Tissue Distribution; Xenograft Model Antitumor Assays	2011
Dosimetric model for intraperitoneal targeted liposomal radioimmunotherapy of ovarian cancer micrometastases. Physics in medicine and biology, 2003, May-21, Volume: 48, Issue:10 Topics: Biophysical Phenomena; Biophysics; CA-125 Antigen; Computer Simulation; Female; Humans; Injections, Intraperitoneal; Liposomes; Models, Biological; Ovarian Neoplasms; Peritoneal Neoplasms; Radioimmunotherapy; Radioisotopes; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Rhenium	2003
The processing and fate of antibodies and their radiolabels bound to the surface of tumor cells in vitro: a comparison of nine radiolabels. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1994, Volume: 35, Issue:5 Topics: Acetylgalactosamine; Animals; Antibodies, Monoclonal; Female; Indium Radioisotopes; Inulin; Iodine Radioisotopes; Kidney Neoplasms; Ovarian Neoplasms; Radioimmunotherapy; Radioisotopes; Rhenium; Serum Albumin, Bovine; Tumor Cells, Cultured; Tyramine	1994
Comparison of the biodistribution and the efficacy of monoclonal antibody 323/A3 labeled with either 131I or 186Re in human ovarian cancer xenografts. International journal of radiation oncology, biology, physics, 1997, Jul-01, Volume: 38, Issue:4 Topics: Animals; Antibodies, Monoclonal; Female; Humans; Iodine Radioisotopes; Mice; Mice, Nude; Organotechnetium Compounds; Ovarian Neoplasms; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Rhenium; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured	1997
Radiolabeling of monoclonal antibody B43.13 with rhenium-188 for immunoradiotherapy. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 1997, Volume: 48, Issue:7 Topics: Animals; Antibodies, Monoclonal; Cell Line; Drug Stability; Female; Humans; Mice; Mice, Inbred BALB C; Mice, SCID; Ovarian Neoplasms; Radioimmunotherapy; Radioisotopes; Rhenium; Tissue Distribution; Transplantation, Heterologous	1997
[186Re]-labeled mouse and chimeric monoclonal antibody 323/A3: a comparison of the efficacy in experimental human ovarian cancer. Nuclear medicine and biology, 1998, Volume: 25, Issue:1 Topics: Animals; Antibodies, Monoclonal; Chelating Agents; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Glycine; Humans; Immunotoxins; Isoelectric Point; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Radioimmunotherapy; Radioisotopes; Recombinant Fusion Proteins; Rhenium; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured	1998
188Re DD-3B6/22 Fab' for use in therapy of ovarian cancer: labelling and animal studies. Nuclear medicine and biology, 1998, Volume: 25, Issue:7 Topics: Animals; Ascorbic Acid; Female; Gluconates; Immunoglobulin Fab Fragments; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Oxidation-Reduction; Radioimmunodetection; Radioisotopes; Radiopharmaceuticals; Radiotherapy; Rhenium; Technetium	1998
Clinical trials available using radiolabeled MoAbs against colon cancer, lung cancer, ovarian cancer, and hepatic metastases. Oncology (Williston Park, N.Y.), 1990, Volume: 4, Issue:8 Topics: Antibodies, Monoclonal; Clinical Trials as Topic; Colonic Neoplasms; Female; Humans; Liver Neoplasms; Lung Neoplasms; Ovarian Neoplasms; Radioisotopes; Rhenium	1990
Killer antibodies enter clinical trial against ovarian cancer. Journal of the National Cancer Institute, 1990, Apr-04, Volume: 82, Issue:7 Topics: Adenocarcinoma; Antibodies, Monoclonal; Drug Evaluation; Female; Humans; Ovarian Neoplasms; Radioisotopes; Rhenium	1990